ARTICLE | Company News
Matritech, Stellar International Inc. deal
October 27, 2003 8:00 AM UTC
Canadian specialty pharma company SSY received exclusive rights to market NMPS's NMP22 BladderChek test to diagnose and monitor bladder cancer. BladderChek is approved by the FDA for use in physician...